---
title: "₹2,700 Cancer Drug Carries ₹27,000 MRP; “If This Is Not Looting, What Is?”: Justice Sandeep Mehta"
english_title: "Supreme Court Questions Huge Price Gap Between Cancer Drug PTR and MRP"
publisher: "Truevision English News"
canonical_url: "https://english.truevisionnews.com/news/383851/ supreme-court-questions-cancer-drug-ptr-mrp-price-gap"
published_at: "2026-09-23T05:27:00+05:30"
category: "National"
language: "en"
image: "https://cf.zdn.im/img/truevisionnews.com/0/image-uploads/6ab3170874ee5_supreme-court-questions-cancer-drug-ptr-mrp-price-gap.jpg"
keywords: ["Supreme Court", "Cancer Medicines", "Drug Prices", "MRP", "Sandeep Mehta", "Price To Retailer"]
---

# ₹2,700 Cancer Drug Carries ₹27,000 MRP; “If This Is Not Looting, What Is?”: Justice Sandeep Mehta

> **Lead Summary:** > **New Delhi: **The Supreme Court has expressed concern over the huge gap between the price at which cancer medicines are sold by manufacturers to retailers and the maximum retail price printed on the medicines. The court observed that allowing a medicine supplied to a retailer for ₹2,700 to carry an MRP of ₹27,000 was equivalent to “looting.” The observations were made while hearing petitions seeking regulation of medicine prices.

## Article Content

> **New Delhi: **The Supreme Court has expressed concern over the huge gap between the price at which cancer medicines are sold by manufacturers to retailers and the maximum retail price printed on the medicines. The court observed that allowing a medicine supplied to a retailer for ₹2,700 to carry an MRP of ₹27,000 was equivalent to “looting.” The observations were made while hearing petitions seeking regulation of medicine prices.

> “If this is not looting, what is it?” Justice Sandeep Mehta asked. He also pointed out that people sometimes sell their houses and jewellery to purchase medicines. The Supreme Court further noted that medicines are being sold to retailers at prices lower than the MRP printed on the products.

The court questioned why manufacturers are permitted to fix an MRP several times higher than the actual selling price. Justice Mehta said that some essential medicines used for cancer treatment have an MRP of ₹27,000, while the PTR (Price To Retailer) is only ₹2,700.

> “This is complete anarchy, daylight robbery. How can a medicine that the manufacturer supplies to the retailer for ₹2,700 have an MRP of ₹27,000 printed on it? Ten times!” Justice Sandeep Mehta said.

> Justice Mehta also said it was surprising that the authorities responsible for taking decisions on the matter were completely silent. “We need not spell out the reason for that,” he added.

> “Why is there this price difference? If, in reality, a medicine is being supplied by the manufacturer to the retailer at 10 per cent of its MRP, why is such a high MRP being fixed? Why is there such a huge gap?” Justice Mehta asked.

The observations were made by a bench comprising Justice Sandeep Mehta and Justice Vikram Nath while considering petitions filed by Kishan Chand Jain and Dr. Sanjay Kulshreshtha concerning regulation of medicine prices, generic medicines, medical devices and prescription practices.

### Related Links & Sources
- [Original Story Source](https://english.truevisionnews.com/news/383851/ supreme-court-questions-cancer-drug-ptr-mrp-price-gap)